Clinician Quiz: Recommendations on Treatment Approaches for Eating Disorders

Quiz
Article

Check your knowledge on the American Psychiatric Association 2023 practice guideline for the treatment of patients with eating disorders.

The American Psychiatric Association Practice Guideline for The Treatment of Patients With Eating Disorder, Fourth Edition (2023) provides recommendations for the treatment of various eating disorders. The guideline suggests individualized goals for weight gain and target weight in anorexia nervosa, eating disorder-focused psychotherapy for adults with anorexia nervosa, and family-based treatment for adolescents with anorexia nervosa.

For bulimia nervosa, cognitive-behavioral therapy and a serotonin reuptake inhibitor are recommended for adults and family-based treatment is suggested for adolescents. Patients with binge-eating disorder are recommended to receive cognitive-behavioral therapy, interpersonal therapy, or medication if psychotherapy alone is not effective. The guideline underlines the importance of personalized treatment plans and a multidisciplinary approach to address the physical and psychological aspects of eating disorders.

Test your knowledge of treatment guidelines for eating disorders with this clinician quiz:

According to the APA Practice Guideline for Eating Disorders, what is the recommended first-line treatment for adults with anorexia nervosa?


References

The American Psychiatric Association Practice Guideline For The Treatment Of Patients With Eating Disorders, Fourth Edition. American Psychiatric Association. 2023. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890424865. Accessed February 23, 2024.

Related Videos
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
© 2024 MJH Life Sciences

All rights reserved.